| Target Price | HK$12.24 |
| Price | HK$9.09 |
| Potential |
34.73%
register free of charge
|
| Number of Estimates | 24 |
|
24 Analysts have issued a price target CSPC Pharmaceutical Group Limited 2027 .
The average CSPC Pharmaceutical Group Limited target price is HK$12.24.
This is
34.73%
register free of charge
HK$20.33
123.75%
register free of charge
HK$8.08
11.06%
register free of charge
|
|
| A rating was issued by 29 analysts: 23 Analysts recommend CSPC Pharmaceutical Group Limited to buy, 4 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CSPC Pharmaceutical Group Limited stock has an average upside potential 2027 of
34.73%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 30.50 | 38.56 |
| 10.35% | 26.44% | |
| EBITDA Margin | 22.56% | 35.96% |
| 6.12% | 59.40% | |
| Net Margin | 14.93% | 25.49% |
| 0.06% | 70.76% |
25 Analysts have issued a sales forecast CSPC Pharmaceutical Group Limited 2026 . The average CSPC Pharmaceutical Group Limited sales estimate is
This results in the following potential growth metrics:
25 CSPC Pharmaceutical Group Limited Analysts have issued a net profit forecast 2026. The average CSPC Pharmaceutical Group Limited net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 0.40 | 0.85 |
| 6.98% | 112.50% | |
| P/E | 10.65 | |
| EV/Sales | 2.23 |
25 Analysts have issued a CSPC Pharmaceutical Group Limited forecast for earnings per share. The average CSPC Pharmaceutical Group Limited EPS is
This results in the following potential growth metrics and future valuations:
CSPC Pharmaceutical Group Limited...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


